A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants

Objectives: To assess the safety and reactogenicity of single oral dose of heat-stable rotavirus vaccine (HSRV) in healthy adults aged 18–45 years followed by assessment of safety, reactogenicity, and immunogenicity of three doses of HSRV in healthy infants aged 6–8 weeks at enrollment. Trial Design...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Kanchan, Vibhu, Zaman, Khalequ, Aziz, Asma Binte, Zaman, Sheikh Farzana, Zaman, Farzana, Haque, Warda, Khanam, Mahbuba, Karim, Mohammad Mahbubul, Kale, Sachin, Ali, Syed Khalid, Goveia, Michelle G., Kaplan, Susan S., Gill, Davinder, Khan, Wasif Ali, Yunus, Mohammad, Singh, Ajitpal, Clemens, John D.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227685/
https://ncbi.nlm.nih.gov/pubmed/31526218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1664239
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars